Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.
about
Claudin 1 in Breast Cancer: New InsightsSomatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysisUnraveling the microenvironmental influences on the normal mammary gland and breast cancerSelective genomic copy number imbalances and probability of recurrence in early-stage breast cancerUnraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis.Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays.Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.Rare breast cancer subtypes: histological, molecular, and clinical peculiaritiesMost basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation.Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.Clinicopathologic characteristics of typical medullary breast carcinoma: a retrospective study of 117 cases.Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas.TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical studyIdentification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.Genomic insights into triple-negative and HER2-positive breast cancers using isogenic model systemsPrognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.Management options in triple-negative breast cancerAberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers.A gene signature for predicting outcome in patients with basal-like breast cancer.Basal-like breast cancer: molecular profiles, clinical features and survival outcomesPrognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancerAssociation of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast CancerEarly onset of breast cancer in a group of British black womenImmunophenotypic and genomic characterization of papillary carcinomas of the breast.Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.Identification of Copy Number Aberrations in Breast Cancer Subtypes Using Persistence Topology.Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast.Carcinoma of the breast with medullary-like features: diagnostic challenges and relationship with BRCA1 and EZH2 functions.Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer.Breast carcinoma--rare types: review of the literature.Genomic architecture characterizes tumor progression paths and fate in breast cancer patients.Histological types of breast cancer: how special are they?Triple-negative breast cancer: present challenges and new perspectives.Beyond triple-negative breast cancer: the need to define new subtypes.Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.Breast cancer pathology: the impact of molecular taxonomy on morphological taxonomy.
P2860
Q26774988-C83C61C9-3E18-4DD8-AB8B-45AC48763C10Q26776018-2B40B252-6ADF-4025-B61B-E1F81129711DQ28473677-9AF943A5-2077-4CC0-AF38-91A966D6C763Q28741460-BF08F4DC-591A-4B1F-9D12-529A191C7740Q33570282-A6C657AD-A534-4DB3-BD2A-317E2EF6F491Q33607569-7DFF09F1-D75D-4FCD-930A-9B0C2473E4F2Q33627191-AAE9742D-FD1B-4953-88CD-C684C955388CQ33751806-08F363E7-284C-46BA-B939-8C091C47F4EAQ34005143-719CE209-911B-4CAA-82C4-02FB7162D6EBQ34248718-497480DA-83B7-4B2D-AF9D-CE0A7F393818Q34256029-3D150757-A82F-4CCF-8108-472CE90A0DE1Q34292236-6E13C02F-A168-4CA9-B6E0-087569587C92Q34465749-C797997E-FE86-464F-9FCF-52CC4F76E15BQ34668723-C09D6530-D674-4167-A4B7-30921174D916Q34735167-975A077B-6309-419E-A4BA-476004B630FDQ34839826-8786AB26-2E13-4A95-B07A-DA86E4203D83Q34977042-F497B2DA-8FB2-45CD-98FB-14A9DCE6AF9FQ35005300-2DAAD40C-72E8-40DE-9815-2C1CB409800EQ35049225-4CE40C54-210C-4A15-8033-EE41258341C6Q35155460-9DA21808-6C75-45C4-8CD6-F19D7B49F8A4Q35623021-E337CE08-89D0-488F-8A07-38809121C517Q35675013-25BC3DE6-A454-4BF2-9938-F81C6742B7ECQ36325873-58132477-7618-42F4-BF84-4854C0E6DF51Q36337755-A5BF62FE-1B55-45E7-A389-B3317BF5CC7DQ36353160-7E28EDB8-672B-498C-A8A3-1F04A265341AQ36463604-8EA13353-47C3-4D5E-99A7-B4E6E5802313Q36614754-80F559D9-AA80-41D2-BE37-AFE987370D8DQ37130628-8EEC41EA-4B43-4D21-B90E-587217C884D9Q37131339-6263723D-B6D1-40F6-9D3D-D94E2C97E09DQ37200784-18864F24-3A8E-4540-9F64-B6F1C4354581Q37284899-1EF3BF94-31A2-4FD5-8311-607A207B4119Q37326793-CF972BFA-BF71-456C-938C-FE3C68F04A9DQ37388751-8342F1D8-E2C8-4C40-B9D1-731D4D799327Q37551363-0D1713C9-7CFE-47AF-A795-BEDB6F654342Q37678826-1B95C29E-AA72-4B3E-8510-0C2BAE686B0CQ37746023-0502F317-0CD8-45D5-890E-5E5A967291A5Q37764168-A237623C-3E78-4FCD-8346-197305E9B6DDQ37782088-61B36EEA-22E5-4114-8DE4-3C1D3A5BA7A8Q37809456-BBCCE86D-D569-4BA8-A979-229BC7FA8BD0Q38004624-65981105-E487-4B1D-B54C-87935748A81F
P2860
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Identification of typical medu ...... ogeneous new molecular entity.
@ast
Identification of typical medu ...... ogeneous new molecular entity.
@en
type
label
Identification of typical medu ...... ogeneous new molecular entity.
@ast
Identification of typical medu ...... ogeneous new molecular entity.
@en
prefLabel
Identification of typical medu ...... ogeneous new molecular entity.
@ast
Identification of typical medu ...... ogeneous new molecular entity.
@en
P2093
P2860
P50
P356
P1476
Identification of typical medu ...... ogeneous new molecular entity.
@en
P2093
Alain Aurias
Alain Fourquet
Brigitte Sigal-Zafrani
Carlo Lucchesi
Corinne Taris
Gaëlle Pierron
Gaëtan MacGrogan
Isabelle de Mascarel
Jean-Yves Pierga
Michel Longy
P2860
P2888
P356
10.1186/BCR1666
P50
P577
2007-01-01T00:00:00Z
P5875
P6179
1042824689